Kilpatrick Townsend’s Silicon Valley-based start-up team advised the founders of Editas Medicine in the biotech start-up’s $43 million Series A Financing. In a trend setting transaction, venture firms Polaris Partners, Third Rock Ventures, Flagship Ventures and the Partners Innovation Fund invited five of the most prominent research scientists in the field of genomics from MIT, Harvard, the Howard Hughes Medical Institute and the University of California in Berkeley to form a company which they would fund. The money invested will fund the collaborative research and development by this world-class team of scientists as they seek to revolutionize the treatment of genetic disorders by developing a simple, precise and inexpensive method of ‘editing out’ abnormalities in genes in human cells.

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Acquiring majority ownership interest for a U.S.-based outsourcing services company
Served as lead counsel in representing a U.S.-based outsourcing services company in acquiring majority ownership interest in India-based more
Contract advice for Eltel Networks Infranet AB
Represented Eltel Networks Infranet AB, a leading European Infranet service company specializing in electricity and telecommunications networks, in more
Project Counsel to the School District of Greenville County, South Carolina in Connection With U.S. $1 Billion Fast-Track Renovation and New School Development Program
Project counsel to the Greenville County, South Carolina School District in connection with its innovative U.S. $1 billion plan to design and more
Private investments for a major institutional investor
Represented a major institutional investor in connection with over 30 investments, with an aggregate value of nearly $3 billion, in various private more